Description
BSE lists 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 01, 2025.
Summary
BSE has announced the listing of 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were kept in abeyance. These shares will be permitted to trade with effect from Monday, September 01, 2025.
Key Points
- 1000 bonus equity shares of Rs. 1/- each being listed
- Shares were previously kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers: 1171453 to 1172452
- Trading to commence from September 01, 2025
Regulatory Changes
No regulatory changes introduced. This is an administrative listing of previously issued but held-back bonus shares.
Compliance Requirements
Trading members are informed about the new securities available for trading from the effective date.
Important Dates
- Effective Date: Monday, September 01, 2025 - Trading commencement date
- Notice Date: August 29, 2025
Impact Assessment
Minimal market impact as this involves a small number of bonus shares (1000 shares) of Ipca Laboratories being released from abeyance status. The shares represent a negligible portion relative to the company’s total equity base.
Impact Justification
Administrative listing of small number of bonus shares kept in abeyance with minimal market impact